Steven Cohen’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
Steven Cohen's DNLI Position: Q3 2026 in Review
Steven Cohen opened a new position in Denali Therapeutics (DNLI) in Q3 2026: 61,189 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #2677 among its holdings. This is a return to the name: Steven Cohen previously reported a position in DNLI as recently as Q4 2025.
Steven Cohen first reported a position in DNLI in Q3 2022 and has held it in 11 quarters since. The position peaked at $36.6M in Q3 2025. 287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.
- Steven Cohen held 61,189 shares of Denali Therapeutics worth $1.26M as of Q3 2026.
- Denali Therapeutics was a new Steven Cohen position in Q3 2026.
- Denali Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2677 holding.
- Steven Cohen first reported a position in Denali Therapeutics in Q3 2022 and has held it in 11 quarters since.
- Steven Cohen's Denali Therapeutics position peaked at $36.6M in Q3 2025.
- 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.